02.09.2010 16:00:00
|
Humana Names Stephen Macias Specialty Market President in Northern California
Humana Inc. (NYSE: HUM) announced that Stephen Macias has been appointed market president for the company’s specialty-product business in Northern California, effective today.
In this role, Macias will be responsible for sales of Humana’s specialty products, such as vision, dental, life and workplace disability, in Northern California. Based in Walnut Creek, Macias will manage a team of sales representatives and account executives focused on new-business sales development and customer relations.
During his 12 years working in the health care field, Macias has distinguished himself in progressively responsible leadership roles. Most recently, he served as Humana’s market practice leader for small-business health insurance sales in Arizona, where he was responsible for all health insurance products sold in the state to employers with 99 or fewer employees. Prior to that, Macias was employed at Health Net of Arizona where he was the director of Medicare sales and operations and the manager of individual and family plans. Macias began his career at Blue Cross and Blue Shield of Arizona working with health insurance brokers.
Macias holds a bachelor’s degree from Grand Canyon University and a Masters of Business Administration in health care management from the University of Phoenix. A long-time Arizona-resident, Macias and his family are relocating to Northern California.
About Humana
Humana Inc., headquartered in Louisville, Kentucky, is one of the nation’s largest publicly traded health and specialty benefits companies, with approximately 10.3 million medical members and approximately 7.3 million specialty-benefit members. Humana is a full-service benefits solutions company, offering a wide array of health and specialty benefit plans for employer groups, government programs and individuals.
Over its 49-year history, Humana has consistently seized opportunities to meet changing customer needs. Today, the company is a leader in consumer engagement, providing guidance that leads to lower costs and a better health plan experience throughout its diversified customer portfolio.
More information regarding Humana is available to investors via the Investor Relations page of the company’s Web site at http://www.humana.com, including copies of:
- Annual reports to stockholders
- Securities and Exchange Commission filings
- Most recent investor conference presentations
- Quarterly earnings news releases
- Replays of most recent earnings release conference calls
- Calendar of events (includes upcoming earnings conference call dates and times, as well as planned interaction with research analysts and institutional investors)
- Corporate Governance Information
Wenn Sie mehr über das Thema Aktien erfahren wollen, finden Sie in unserem Ratgeber viele interessante Artikel dazu!
Jetzt informieren!
Nachrichten zu Humana Inc.mehr Nachrichten
24.01.25 |
S&P 500-Titel Humana-Aktie: So viel Verlust hätte eine Humana-Investition von vor einem Jahr eingebracht (finanzen.at) | |
17.01.25 |
S&P 500-Titel Humana-Aktie: So viel hätten Anleger mit einem Investment in Humana von vor 10 Jahren verdient (finanzen.at) | |
17.01.25 |
S&P 500-Handel aktuell: S&P 500-Anleger greifen zum Handelsstart zu (finanzen.at) | |
13.01.25 |
Pluszeichen in New York: S&P 500 zum Handelsende fester (finanzen.at) | |
13.01.25 |
Schwache Performance in New York: S&P 500 zeigt sich schwächer (finanzen.at) | |
13.01.25 |
Börse New York in Rot: So steht der S&P 500 am Montagmittag (finanzen.at) | |
13.01.25 |
NYSE-Handel S&P 500 verbucht zum Start des Montagshandels Abschläge (finanzen.at) | |
10.01.25 |
S&P 500-Wert Humana-Aktie: So viel hätte eine Investition in Humana von vor 5 Jahren gekostet (finanzen.at) |
Analysen zu Humana Inc.mehr Analysen
Aktien in diesem Artikel
Humana Inc. | 277,90 | 0,91% |
Indizes in diesem Artikel
S&P 500 | 6 101,24 | -0,29% |